Acrivon Therapeutics CEO, EVP report stock sales
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
At Acrivon Therapeutics, Inc. (ACRV), President and CEO Peter Blume-Jensen and EVP - Business Operations Kristina Masson reported shares sold on November 17, 2026: 1,276 shares held directly by Blume-Jensen and 504 shares held indirectly by Masson, at a reported weighted-average price of $1.45 per share. A broker made the sales to satisfy mandatory tax withholding upon restricted stock unit vesting. Reported post-transaction holdings were 2,228,776 shares for Blume-Jensen and 385,355 shares for Masson. No Rule 10b5-1 plan is reported.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1, F2, F3 | 1,276 | $1.45 | $2K |
| Sale | Common Stock F1, F2, F4 | 504 | $1.45 | $730.80 |
Footnotes (4)
- F1. Shares sold automatically to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.
- F2. The price reported in Column 4 above reflects the weighted average price of 4,070 shares sold by a broker on November 17, 2026, to satisfy the payment of withholding tax liability of a group of employees of the Issuer, including the reporting persons. The proceeds of all such sales were allocated to the employees, including the reporting persons, on a pro rata basis.
- F3. These securities are held by President and CEO, Dr. Peter Blume-Jensen, who is also Dr. Kristina Masson's spouse. Dr. Masson disclaims beneficial ownership of such securities except to the extent of her pecuniary interest therein.
- F4. These securities are held by co-founder and EVP, Dr. Kristina Masson, who is also Dr. Blume-Jensen's spouse. Dr. Blume-Jensen disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
Key Figures
Key Terms
restricted stock units financial
weighted average price financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.